Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Doxorubicin by InnoMedica for Ovarian Cancer: Likelihood of Approval
Doxorubicin is under clinical development by InnoMedica and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
Doxorubicin by InnoMedica for Breast Cancer: Likelihood of Approval
Doxorubicin is under clinical development by InnoMedica and currently in Phase II for Breast Cancer. According to GlobalData, Phase II...
TLSG-1 by InnoMedica for Parkinson's Disease: Likelihood of Approval
TLSG-1 is under clinical development by InnoMedica and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...